Nitrazepam Aurobindo (Nitrazepam)

Nitrazepam is a benzodiazepine that modulates central nervous system activity and is indicated for several sleep‑related and neurological conditions.

• Insomnia: Improves sleep onset and maintenance in patients with difficulty falling or staying asleep.
• Anxiety disorders: Reduces excessive tension and worry in generalized anxiety or acute stress situations.
• Seizure disorders: Controls certain types of epileptic seizures, particularly those responsive to benzodiazepine therapy.

• Nitrazepam acts as a positive allosteric modulator of the GABA‑A receptor complex. By binding to the benzodiazepine site, it enhances the affinity of the receptor for the inhibitory neurotransmitter gamma‑aminobutyric acid, increasing chloride ion influx and hyperpolarizing neuronal membranes. This potentiation of GABA‑mediated inhibition produces sedative, anxiolytic, muscle‑relaxant and anticonvulsant effects. The overall result is a reduction in neuronal excitability across multiple brain regions involved in sleep regulation, anxiety processing and seizure generation.

Nitrazepam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Drowsiness: Excessive sleepiness during daytime.
• Fatigue: General feeling of low energy.
• Dizziness: Light‑headed sensation, especially when standing quickly.
• Impaired coordination: Reduced motor control and balance.
• Memory disturbances: Short‑term recall difficulties.
• Headache: Mild to moderate cranial pain.
• Blurred vision: Temporary visual disturbances.
• Nausea: Stomach upset or queasiness.

Serious or Rare Side Effects

• Respiratory depression: Slowed breathing that may require medical attention.
• Severe allergic reaction: Rash, swelling, or anaphylaxis.
• Depression or suicidal thoughts: Mood changes requiring urgent evaluation.
• Paradoxical agitation: Increased anxiety or aggression instead of calming.
• Dependence and withdrawal: Physical reliance with symptoms on abrupt cessation.
• Liver function abnormalities: Elevated enzymes indicating hepatic stress.
• Psychomotor impairment: Slowed reaction time affecting tasks like driving.
• Seizure worsening: Rare increase in seizure frequency.

When prescribing Nitrazepam, clinicians should consider several precautionary measures to minimize risks.

• Assess renal and hepatic function: Adjust use if significant impairment is present.
• Review concomitant CNS depressants: Avoid additive sedation with alcohol, opioids or antihistamines.
• Evaluate dependence risk: Limit duration and monitor for signs of tolerance.
• Pregnancy and lactation: Contraindicated in pregnancy (Category D) and not recommended while breastfeeding.
• Elderly patients: Use lower doses and monitor for falls or confusion.
• Store at ambient temperature: Keep below 25 °C in the original container, protect from moisture and light.

Nitrazepam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Opioids: Combined CNS depression may cause profound respiratory depression.
• Barbiturates: Counteract sedative effect and increase seizure risk.
• Antifungal azoles (e.g., ketoconazole): Inhibit metabolism, raising nitrazepam plasma levels.

Moderate Interactions (Monitor Closely)

• Antidepressants (SSRIs, SNRIs): May enhance sedation or serotonergic effects.
• Antihistamines: Additive drowsiness.
• Oral contraceptives: May reduce contraceptive efficacy.
• Antiepileptic drugs (phenytoin, carbamazepine): May lower nitrazepam concentrations.